Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

Epidemiology of anxiety disorders in the 21st century

Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079 · see citing works

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior

Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340 · see citing works

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · see citing works

Generalized Anxiety Disorder

Stein, M. B., & Sareen, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1502514 · Cited by 523 · see citing works

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

Storkebaum, E., Lambrechts, D., & Carmeliet, P. (2004) · BioEssays · doi:10.1002/bies.20092 · Cited by 505 · see citing works

Epidemiology of Anxiety Disorders

Kessler, R. C., Ruscio, A. M., Shear, K., & Wittchen, H.-U. (2009) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2009_9 · Cited by 496 · see citing works

BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis

Polyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., & Schroeter, M. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.044 · Cited by 488 · see citing works

Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis

Taliaz, D., Stall, N., Dar, D. E., & Zangen, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.67 · Cited by 454 · see citing works

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment

Lee, B.-H., & Kim, Y. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.4.231 · Cited by 447 · see citing works

Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder

Aston, C., Jiang, L., & Sokolov, B. P. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001565 · Cited by 427 · see citing works

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes

Cunha, A. B. M., Frey, B. N., Andreazza, A. C., Goi, J. D., Rosa, A. R., Gonçalves, C. A., Santin, A. M. P., & Kapczinski, F. P. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.085 · Cited by 391 · see citing works

Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis

Fernandes, B. S., Gama, C. S., Maria Ceresér, K., Yatham, L. N., Fries, G. R., Colpo, G., de Lucena, D., Kunz, M., Gomes, F. A., & Kapczinski, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.002 · Cited by 389 · see citing works

Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania

Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5216-05.2006 · Cited by 341 · see citing works

Decreased plasma BDNF level in depressive patients

Lee, B.-H., Kim, H., Park, S., & Kim, Y. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.11.005 · Cited by 327 · see citing works

Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy

Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315 · see citing works

Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes

del Pino, I., García-Frigola, C., Dehorter, N., Brotons-Mas, J. R., Alvarez-Salvado, E., Martínez de Lagrán, M., Ciceri, G., Gabaldón, M. V., Moratal, D., Dierssen, M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.010 · Cited by 314 · see citing works

The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis

Trejo, J. L., Llorens-Martı́n, M., & Torres‐Alemán, I. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.10.016 · Cited by 287 · see citing works

Variant Brain-Derived Neurotrophic Factor Val66Met Polymorphism Alters Vulnerability to Stress and Response to Antidepressants

Yu, H., Wang, D.-D., Wang, Y., Liu, T., Lee, F. S., & Chen, Z.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5048-11.2012 · Cited by 275 · see citing works

Genetic and Stress-Induced Loss of NG2 Glia Triggers Emergence of Depressive-like Behaviors through Reduced Secretion of FGF2

Birey, F., Kloc, M. L., Chavali, M., Hussein, I., Wilson, M., Christoffel, D. J., Chen, T., Frohman, M. A., Robinson, J. K., Russo, S. J., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.046 · Cited by 204 · see citing works

Prenatal stress decreases <i>Bdnf</i> expression and increases methylation of <i>Bdnf</i> exon IV in rats

Boersma, G. J., Lee, R. S., Cordner, Z. A., Ewald, E. R., Purcell, R. H., Moghadam, A. A., & Tamashiro, K. L. (2014) · Epigenetics · doi:10.4161/epi.27558 · Cited by 172 · see citing works

Antidepressant Effects of Fibroblast Growth Factor-2 in Behavioral and Cellular Models of Depression

Elsayed, M., Banasr, M., Duric, V., Fournier, N. M., Licznerski, P., & Duman, R. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.003 · Cited by 169 · see citing works

The Fibroblast Growth Factor Family: Neuromodulation of Affective Behavior

Turner, C. A., Watson, S. J., & Akil, H. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.037 · Cited by 160 · see citing works

Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis

Munkholm, K., Vinberg, M., & Kessing, L. V. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.54 · Cited by 157 · see citing works

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice

Deltheil, T., Guiard, B. P., Cerdan, J., David, D. J., Tanaka, K. F., Repérant, C., Guilloux, J.-P., Coudoré, F., Hen, R., & Gardier, A. M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.001 · Cited by 153 · see citing works

The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder

Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150 · see citing works

Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients

Futamura, T., Toyooka, K., Iritani, S., Niizato, K., Nakamura, R., Tsuchiya, K., Someya, T., Kakita, A., Takahashi, H., & Nawa, H. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001081 · Cited by 146 · see citing works

A New Role for FGF2 as an Endogenous Inhibitor of Anxiety

Perez, J. A., Clinton, S. M., Turner, C. A., Watson, S. J., & Akil, H. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4829-08.2009 · Cited by 145 · see citing works

Nrf2 participates in depressive disorders through an anti-inflammatory mechanism

Martín-de-Saavedra, M. D., Budni, J., Cunha, M. P., Gómez-Rangel, V., Lorrio, S., del Barrio, L., Lastres-Becker, I., Parada, E., Tordera, R. M., Rodrigues, A. L. S., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.020 · Cited by 143 · see citing works

Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies

Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.067 · Cited by 142 · see citing works

An inverse relationship between cortisol and BDNF levels in schizophrenia: Data from human postmortem and animal studies

Issa, G., Wilson, C., Terry, A. V., & Pillai, A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.017 · Cited by 139 · see citing works

Decreased mRNA and Protein Expression of BDNF, NGF, and their Receptors in the Hippocampus from Suicide: An Analysis in Human Postmortem Brain

Banerjee, R., Ghosh, A. K., Ghosh, B., Bhattacharyya, S., & Mondal, A. C. (2013) · Clinical Medicine Insights: Pathology · doi:10.4137/cpath.s12530 · Cited by 135 · see citing works

Interaction between BDNF Val66Met and Dopamine Transporter Gene Variation Influences Anxiety-Related Traits

Hünnerkopf, R., Strobel, A., Gutknecht, L., Brocke, B., & Lesch, K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301383 · Cited by 129 · see citing works

Encyclopedia of Psychopharmacology

Stolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2 · Cited by 129 · see citing works

The relevance of ‘mixed anxiety and depression’ as a diagnostic category in clinical practice

Möller, H.-J., Bandelow, B., Volz, H.-P., Barnikol, U. B., Seifritz, E., & Kasper, S. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0684-7 · Cited by 127 · see citing works

Antidepressant-like effects of intracerebroventricular FGF2 in rats

Turner, C. A., Gula, E. L., Taylor, L. P., Watson, S. J., & Akil, H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.088 · Cited by 125 · see citing works

Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment

Musil, R., Schwarz, M., Riedel, M. J., Dehning, S., Cerovecki, A., Spellmann, I., Arolt, V., & Müller, N. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.047 · Cited by 125 · see citing works

5-HT2C receptors in psychiatric disorders: A review

Chagraoui, A., Thibaut, F., Skiba, M., Thuillez, C., & Bourin, M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.12.006 · Cited by 122 · see citing works

Neuronal Correlates of Brain-derived Neurotrophic Factor Val66Met Polymorphism and Morphometric Abnormalities in Bipolar Disorder

Matsuo, K., Walss‐Bass, C., Nery, F. G., Nicoletti, M., Hatch, J. P., Frey, B. N., Monkul, E. S., Zunta‐Soares, G. B., Bowden, C. L., Escamilla, M. A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.23 · Cited by 115 · see citing works

Decreased mRNA and Protein Expression of BDNF, NGF, and their Receptors in the Hippocampus from Suicide: An Analysis in Human Postmortem Brain.

Banerjee, R., Ghosh, A. K., Ghosh, B., et al. (2013) · PubMed · doi:10.4137/cmpath.s12530 · Cited by 113 · see citing works

Effects of the Brain-Derived Neurotrophic Growth Factor Val66Met Variation on Hippocampus Morphology in Bipolar Disorder

Chepenik, L. G., Fredericks, C. A., Papademetris, X., Spencer, L., Lacadie, C., Wang, F., Pittman, B. P., Duncan, J. S., Staib, L. H., Duman, R. S., et al. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.107 · Cited by 112 · see citing works

Gestational stress induces depressive-like and anxiety-like phenotypes through epigenetic regulation of BDNF expression in offspring hippocampus

Zheng, Y., Fan, W., Zhang, X., & Dong, E. (2016) · Epigenetics · doi:10.1080/15592294.2016.1146850 · Cited by 111 · see citing works

Associations between parenting behavior and anxiety in a rodent model and a clinical sample: relationship to peripheral BDNF levels

Molle, R. D., Portella, A. K., Goldani, M. Z., Kapczinski, F. P., Leistner‐Segal, S., Salum, G. A., Manfro, G. G., & Silveira, P. P. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.126 · Cited by 109 · see citing works

Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain

Jornada, L. K., Moretti, M., Valvassori, S. S., Ferreira, C. L., Padilha, P. T., Arent, C. O., Fries, G. R., Kapczinski, F., & Quevedo, J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.002 · Cited by 107 · see citing works

Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

Miskowiak, K. W., Vinberg, M., Christensen, E. M., Bukh, J. D., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.335 · Cited by 104 · see citing works

Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression

Mitschelen, M., Yan, H., Farley, J. A., Warrington, J. P., Han, S., Hereñú, C. B., Csiszar, A., Ungvari, Z., Bailey-Downs, L. C., Bass, C. E., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.032 · Cited by 103 · see citing works

Epigenetic Mechanisms Underlying the Role of Brain-Derived Neurotrophic Factor in Depression and Response to Antidepressants

Duclot, F., & Kabbaj, M. (2015) · Journal of Experimental Biology · doi:10.1242/jeb.107086 · Cited by 103 · see citing works

Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders

Lester, K., & Eley, T. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-4 · Cited by 103 · see citing works

Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder

Miskowiak, K. W., Ehrenreich, H., Christensen, E. M., Kessing, L. V., & Vinberg, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08839 · Cited by 99 · see citing works

Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders

Miskowiak, K. W., Vinberg, M., Macoveanu, J., Ehrenreich, H., Køster, N., Inkster, B., Paulson, O. B., Kessing, L. V., Skimminge, A., & Siebner, H. R. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.013 · Cited by 99 · see citing works

Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters

Isung, J., Aeinehband, S., Mobarrez, F., Mårtensson, B., Nordström, P., Åsberg, M., Piehl, F., & Jokinen, J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.123 · Cited by 98 · see citing works

Gender-Dependent Modulation of Brain Monoamines and Anxiety-like Behaviors in Mice with Genetic Serotonin Transporter and BDNF Deficiencies

Ren‐Patterson, R. F., Cochran, L. W., Holmes, A., Lesch, K., Lu, B., & Murphy, D. L. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9048-6 · Cited by 97 · see citing works

BDNF Val66Met is Associated with Introversion and Interacts with 5-HTTLPR to Influence Neuroticism

Terracciano, A., Tanaka, T., Sutin, A. R., Deiana, B., Balaci, L., Sanna, S., Olla, N., Maschio, A., Uda, M., Ferrucci, L., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.213 · Cited by 94 · see citing works

Variant Brain-Derived Neurotrophic Factor (Valine66Methionine) Polymorphism Contributes to Developmental and Estrous Stage-Specific Expression of Anxiety-Like Behavior in Female Mice

Bath, K. G., Chuang, J., Spencer-Segal, J. L., Amso, D., Altemus, M. M., McEwen, B. S., & Lee, F. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.032 · Cited by 94 · see citing works

Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders

Lee, B.-H., & Kim, Y. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.021 · Cited by 92 · see citing works

Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals

Turner, C. A., Clinton, S. M., Thompson, R. C., Watson, S. J., & Akil, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103732108 · Cited by 92 · see citing works

Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients

Minelli, A., Zanardini, R., Abate, M., Bortolomasi, M., Gennarelli, M., & Bocchio‐Chiavetto, L. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.04.013 · Cited by 90 · see citing works

GPR39 (Zinc Receptor) Knockout Mice Exhibit Depression-Like Behavior and CREB/BDNF Down-Regulation in the Hippocampus

Młyniec, K., Budziszewska, B., Holst, B., Ostachowicz, B., & Nowak, G. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu002 · Cited by 89 · see citing works

Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk

Wiener, C. D., Ferreira, S. D. M., Moreira, F. P., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.067 · Cited by 89 · see citing works

Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: A study of two independent cohorts

Södersten, K., Pålsson, E., Ishima, T., Funa, K., Landén, M., Hashimoto, K., & Ågren, H. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.01.009 · Cited by 85 · see citing works

Peripheral inflammation during abnormal mood states in bipolar I disorder

Fiedorowicz, J. G., Prossin, A. R., Johnson, C. P., Christensen, G. E., Magnotta, V. A., & Wemmie, J. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.036 · Cited by 81 · see citing works

Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients

Squassina, A., Costa, M. F., Congiu, D., Manchia, M., Angius, A., Deiana, V., Ardau, R., Chillotti, C., Severino, G., Calza, S., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.004 · Cited by 80 · see citing works

Erythropoietin Induction by Electroconvulsive Seizure, Gene Regulation, and Antidepressant-Like Behavioral Effects

Girgenti, M. J., Hunsberger, J. G., Duman, C. H., Sathyanesan, M., Terwilliger, R. Z., & Newton, S. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.005 · Cited by 79 · see citing works

Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone

Cheng, Y., Rodriguiz, R. M., Murthy, S. R. K., Senatorov, V. V., Thouënnon, E., Cawley, N. X., Aryal, D. K., Ahn, S., Lecka‐Czernik, B., Wetsel, W. C., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.136 · Cited by 77 · see citing works

Fibroblast growth factor receptor signaling affects development and function of dopamine neurons – inhibition results in a schizophrenia‐like syndrome in transgenic mice

Klejbor, I., Myers, J. M., Hausknecht, K., Corso, T. D., Gambino, A. S., Moryś, J., Maher, P., Hard, R., Richards, J. C., Stachowiak, E., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03754.x · Cited by 76 · see citing works

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

Viikki, M., Anttila, S. A. K., Kampman, O., Illi, A., Huuhka, M., Setälä-Soikkeli, E., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.039 · Cited by 75 · see citing works

A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia

Nurjono, M., Lee, J., & Chong, S. A. (2012) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2012.10.2.61 · Cited by 75 · see citing works

Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder

Liu, X., Zhang, T., Shen, H., Hong, B., Chen, Z., Peng, D., Wu, Y., Wen, H., Lin, Z., Fang, Y., et al. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.03.042 · Cited by 74 · see citing works

Reduced Serum Nerve Growth Factor in Patients With Late-Life Depression

Diniz, B. S., Teixeira, A. L., Machado‐Vieira, R., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.014 · Cited by 74 · see citing works

Predicting outcomes following cognitive behaviour therapy in child anxiety disorders: the influence of genetic, demographic and clinical information

Hudson, J. L., Lester, K. J., Lewis, C. M., Tropeano, M., Creswell, C., Collier, D. A., Cooper, P., Lyneham, H. J., Morris, T. M., Rapee, R. M., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12092 · Cited by 71 · see citing works

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression

Miskowiak, K. W., Vinberg, M., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2511-1 · Cited by 70 · see citing works

The expression of transforming growth factor-beta1 (TGF-β1) in hippocampal neurons: a temporary upregulated protein level after transient forebrain ischemia in the rat

Zhu, Y. S., Roth-Eichhorn, S., Braun, N., et al. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02240-x · Cited by 69 · see citing works

The brain‐derived neurotrophic‐factor ( <i>BDNF</i> ) val66met polymorphism is associated with geriatric depression: A meta‐analysis

Pei, Y., Smith, A. K., Wang, Y., Pan, Y., Yang, J., Chen, Q., Pan, W., Bao, F., Zhao, L., Tie, C., et al. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32062 · Cited by 67 · see citing works

Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor

Eibl, J. K., Strasser, B. C., & Ross, G. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.10.008 · Cited by 67 · see citing works

Alterations in effective connectivity anchored on the insula in major depressive disorder

Iwabuchi, S. J., Peng, D., Fang, Y., Jiang, K., Liddle, E. B., Liddle, P. F., & Palaniyappan, L. K. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.08.005 · Cited by 67 · see citing works

Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study

Li, Z., Zhang, C., Fan, J., Yuan, C., Huang, J., Chen, J., Yi, Z., Wang, Z., Hong, W., Wang, Y., et al. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.134064 · Cited by 66 · see citing works

Further evidence for the role of interferon-gamma on anxiety- and depressive-like behaviors: Involvement of hippocampal neurogenesis and NGF production

Campos, A. C., Vaz, G. N., Saito, V. M., & Teixeira, A. L. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.039 · Cited by 64 · see citing works

IGF-I in major depression and antidepressant treatment response

Kopczak, A., Stalla, G. K., Uhr, M., Lucae, S., Hennings, J., Ising, M., Holsboer, F., & Kloiber, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.12.013 · Cited by 63 · see citing works

Serum brain-derived neurotrophic factor level in dysthymia: A comparative study with major depressive disorder

Aydemır, Ö., Deveci, A., Taşkın, O., Taneli, F., & Esen-Danacı, A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.02.013 · Cited by 62 · see citing works

Neurotrophic gene polymorphisms and response to psychological therapy

Lester, K. J., Hudson, J. L., Tropeano, M., Creswell, C., Collier, D. A., FARMER, A. E., Lyneham, H. J., Rapee, R. M., & Eley, T. C. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.33 · Cited by 62 · see citing works

Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety

Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Prickaerts, J., Oude Voshaar, R. C., & Elzinga, B. M. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.587892 · Cited by 62 · see citing works

Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression

Gupta, R., Gupta, K., Tripathi, A. K., Bhatia, M. S., & Gupta, L. K. (2016) · Pharmacology · doi:10.1159/000444220 · Cited by 61 · see citing works

Gender differences in the enhanced vulnerability of BDNF+/− mice to mild stress

Advani, T., Koek, W., & Hensler, J. G. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000248 · Cited by 60 · see citing works

Anxiolytic effect of music exposure on BDNFMet/Met transgenic mice

Li, W., Yu, H., Yang, J., Gao, J., Jiang, H., Feng, M. H., Zhao, Y., & Chen, Z.-Y. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.080 · Cited by 58 · see citing works

Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder

Legge, R. M., Sendi, S., Cole, J. H., Cohen‐Woods, S., Costafreda, S. G., Simmons, A., FARMER, A. E., Aitchison, K. J., McGuffin, P., & Fu, C. H. Y. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.143529 · Cited by 57 · see citing works

Fibroblast growth factor 9 is a novel modulator of negative affect

Aurbach, E. L., Inui, E. G., Turner, C. A., Hagenauer, M. H., Prater, K. E., Li, J. Z., Absher, D., Shah, N., Blandino, P., Bunney, W. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510456112 · Cited by 57 · see citing works

Altered choroid plexus gene expression in major depressive disorder

Turner, C. A., Thompson, R. C., Bunney, W. E., Schatzberg, A. F., Barchas, J. D., Myers, R., Akil, H., & Watson, S. J. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00238 · Cited by 56 · see citing works

Essential Roles of Heparin‐Binding Epidermal Growth Factor‐Like Growth Factor in the Brain

Oyagi, A., & Hara, H. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00371.x · Cited by 55 · see citing works

Brain-Derived Neurotrophic Factor Val66Met Polymorphism and 6-Month Antidepressant Remission in Depressed Caucasian Patients

Colle, R., Gressier, F., Verstuyft, C., Deflesselle, E., Lépine, J.-P., Ferreri, F., Hardy, P., Guilloux, J.-P., Petit, A.-C., Fève, B., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.013 · Cited by 55 · see citing works

Hippocampal biomarkers of fear memory in an animal model of generalized anxiety disorder

Dias, G. P., Bevilaqua, M. C. D. N., da Luz, A. C. D. D. S., Fleming, R. L., de Carvalho, L. A., Cocks, G. D., Beckman, D., Hosken, L., Machado, W. D. S., Corrêa-e-Castro, A. C., et al. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.012 · Cited by 55 · see citing works

Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression

Meylan, E. M., Breuillaud, L., Seredenina, T. S., Magistretti, P. J., Halfon, O., Luthi‐Carter, R., & Cardinaux, J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.116 · Cited by 54 · see citing works

Short-Hairpin RNA Silencing of Endogenous Fibroblast Growth Factor 2 in Rat Hippocampus Increases Anxiety Behavior

Eren‐Koçak, E., Turner, C. A., Watson, S. J., & Akil, H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.020 · Cited by 53 · see citing works

Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features

Kotan, Z., Sarandöl, E., Kırhan, E., Özkaya, G., & Kırlı, S. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312436572 · Cited by 53 · see citing works

NGF serum levels variations in major depressed patients receiving duloxetine

Martino, M., Rocchi, G., Escelsior, A., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.02.009 · Cited by 52 · see citing works

The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia

Xiong, P., Zeng, Y., Wan, J., XiaoHan, D. H., Tan, D., Lü, J., Xu, F., Li, H. Y., Zhu, Z., & Ma, M. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.017 · Cited by 52 · see citing works

The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia

Chen, S., Lee, S.-Y., Chang, Y.-H., Chen, S., Chu, C., Wang, T.-Y., Chen, P.-S., Lee, I., Yang, Y.-K., Hong, J.-S., et al. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.012 · Cited by 51 · see citing works

BDNF Methylation and Maternal Brain Activity in a Violence-Related Sample

Moser, D. A., Paoloni-Giacobino, A., Stenz, L., Adouan, W., Manini, A., Suardi, F., Cordero, M. I., Vital, M., Sancho Rossignol, A., Rusconi-Serpa, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143427 · Cited by 51 · see citing works

Neural correlates of improved executive function following erythropoietin treatment in mood disorders

Miskowiak, K. W., Vinberg, M., Glerup, L., Paulson, O. B., Knudsen, G. M., Ehrenreich, H., Harmer, C. J., Kessing, L. V., Siebner, H. R., & Macoveanu, J. (2016) · Psychological Medicine · doi:10.1017/s0033291716000209 · Cited by 51 · see citing works

Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI

Ide, S., Kakeda, S., Watanabe, K., Yoshimura, R., Abe, O., Hayashi, K., Ueda, I., Kishi, T., Katsuki, A., Umene‐Nakano, W., et al. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.05.016 · Cited by 50 · see citing works

Brain-Derived Neurotrophic Factor Val/Met Polymorphism and Bipolar Disorder

Kim, B., Kim, C. Y., Hong, J., Kim, S.-Y., Lee, C., & Joo, Y. (2008) · Neuropsychobiology · doi:10.1159/000162356 · Cited by 50 · see citing works

Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users

Bot, M., Milaneschi, Y., Penninx, B. W. J. H., & Drent, M. L. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.028 · Cited by 50 · see citing works

Interaction between BDNF rs6265 Met allele and low family cohesion is associated with smaller left hippocampal volume in pediatric bipolar disorder

Zeni, C., Mwangi, B., Cao, B., Hasan, K. M., Walss‐Bass, C., Zunta‐Soares, G. B., & Soares, J. C. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.031 · Cited by 46 · see citing works

Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls

Tu, K.-Y., Wu, M., Chen, Y., Lin, P., Wang, H., Wu, C.-K., & Tseng, P. (2016) · Medicine · doi:10.1097/md.0000000000002411 · Cited by 46 · see citing works

Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients

Milanesi, E., Hadar, A., Maffioletti, E., Werner, H., Shomron, N., Gennarelli, M., Schulze, T. G., Costa, M. F., Zompo, M. D., Squassina, A., et al. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0523-8 · Cited by 44 · see citing works

IGF-I levels and depressive disorders: Results from the Study of Health in Pomerania (SHIP)

Sievers, C., Auer, M. K., Klotsche, J., Athanasoulia, A. P., Schneider, H. J., Nauck, M. A., Völzke, H., John, U., Schulz, A., Freyberger, H. J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.008 · Cited by 43 · see citing works

Associations between depressive symptoms and memory deficits vary as a function of insulin-like growth factor (IGF-1) levels in healthy older adults

Lin, F. V., Suhr, J. A., Diebold, S., & Heffner, K. L. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.006 · Cited by 43 · see citing works

Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy

Minelli, A., Maffioletti, E., Bortolomasi, M., et al. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12187 · Cited by 42 · see citing works

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients

Miskowiak, K. W., Favaron, E., Hafizi, S., Inkster, B., Goodwin, G. M., Cowen, P. J., & Harmer, C. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1842-7 · Cited by 40 · see citing works

Insulin-like Growth Factor-I (IGF-I) Serum Concentrations in Depressed Patients: Relationship to Saliva Cortisol and Changes during Antidepressant Treatment

Weber-Hamann, B., Blum, W. F., Kratzsch, J., Gilles, M., Heuser, I., & Deuschle, M. (2009) · Pharmacopsychiatry · doi:10.1055/s-0028-1085442 · Cited by 39 · see citing works

Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder

Shen, H., Zhang, T., Hong, B., Peng, D., Su, H. L., Lin, Z., Fang, Y., Jiang, K., Liu, X., & Li, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.035 · Cited by 39 · see citing works

The role of nerve growth factor and its receptors in tumorigenesis and cancer pain

Wang, W., Chen, J., & Guo, X. (2014) · BioScience Trends · doi:10.5582/bst.8.68 · Cited by 39 · see citing works

High insulin-like growth factor-1 in patients with bipolar I disorder: A trait marker?

Kim, Y., Na, K., Hwang, J.-A., Yoon, H., Lee, H., Hahn, S., Lee, B.-H., & Jung, H. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.041 · Cited by 39 · see citing works

Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: Results of a preliminary study

Halmai, Z., Döme, P., Dobos, J., Gonda, X., Székely, A., Sasvári‐Székely, M., Faludi, G., & Lazáry, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.09.006 · Cited by 38 · see citing works

Nerve growth factor serum concentrations rise after successful cognitive–behavioural therapy of generalized anxiety disorder

Jockers-Scherübl, M. C., Zubrägel, D., Baer, T., Linden, M., Danker‐Hopfe, H., Schulte‐Herbrüggen, O., Neu, P., & Hellweg, R. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.006 · Cited by 37 · see citing works

Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins

Berent, D., Macander, M., Szemraj, J., Orzechowska, A., & Gałecki, P. (2014) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2014-1974 · Cited by 36 · see citing works

Decreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorder

Piccinni, A., Veltri, A., Costanzo, D., Vanelli, F., Franceschini, C., Moroni, I., Domenici, L., Origlia, N., Marazziti, D., Akiskal, H. S., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.08.058 · Cited by 35 · see citing works

Significantly decreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depression

Hong, W., Fan, J.-B. B., Yuan, C., Zhang, C., Hu, Y., Peng, D.-H., Wang, Y., Huang, J., Li, Z.-Z., Yu, S.-Y., et al. (2014) · NeuroReport · doi:10.1097/wnr.0000000000000165 · Cited by 34 · see citing works

Comparison of efficacy, safety and brain derived neurotrophic factor (BDNF) levels in patients of major depressive disorder, treated with fluoxetine and desvenlafaxine

Ghosh, R., Gupta, R., Bhatia, M. S., Tripathi, A. K., & Gupta, L. K. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.10.006 · Cited by 32 · see citing works

Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder

Kikuchi, K., Iga, J., Shibuya‐Tayoshi, S., Nakataki, M., Watanabe, S., Numata, S., & Ohmori, T. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1215 · Cited by 29 · see citing works

A study of the functional significance of epidermal growth factor in major depressive disorder

Tian, W., Zhang, J., Zhang, K., Yang, H., Sun, Y., Shen, Y., & Xu, Q. (2012) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283539550 · Cited by 28 · see citing works

Elevated Brain-Derived Neurotrophic Factor Correlates Negatively with Severity and Duration of Major Depressive Episodes

Kheirouri, S., Noorazar, S. G., Alizadeh, M., & Dana-Alamdari, L. (2016) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000089 · Cited by 28 · see citing works

Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder

Rabie, M. A., Mohsen, M. A. E., Ibrahim, M., & Mahmoud, R. E.-S. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.038 · Cited by 27 · see citing works

Anxiolytic effects of a novel herbal treatment in mice models of anxiety

Doron, R., Lotan, D., Rak-Rabl, A., Raskin-Ramot, A., Lavi, K., & Rehavi, M. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.014 · Cited by 26 · see citing works

Intraamygdala Infusion of Fibroblast Growth Factor 2 Enhances Extinction and Reduces Renewal and Reinstatement in Adult Rats

Graham, B. M., & Richardson, R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3014-11.2011 · Cited by 25 · see citing works

Disruption of the ErbB signaling in adolescence increases striatal dopamine levels and affects learning and hedonic-like behavior in the adult mouse

Golani, I., Tadmor, H., Buonanno, A., Kremer, I., & Shamir, A. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.09.011 · Cited by 24 · see citing works

ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder

Milanesi, E., Minelli, A., Cattane, N., Cattaneo, A., Mora, C., Barbon, A., Mallei, A., Popoli, M., Florio, V., Conca, A., et al. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-145 · Cited by 23 · see citing works

Genetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms on Depressive Disorder

Lee, K. Y., Jeong, S. H., Kim, S. H., Ahn, Y. M., Kim, Y. S., Jung, H. Y., Bang, Y. W., & Joo, E.-J. (2014) · Psychiatry Investigation · doi:10.4306/pi.2014.11.2.192 · Cited by 23 · see citing works

Inherited behaviors, BDNF expression and response to treatment in a novel multifactorial rat model for depression

Gersner, R., Gal, R., Levit, O., Moshe, H., & Zangen, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000030 · Cited by 23 · see citing works

Neuregulin 1 Expression and Electrophysiological Abnormalities in the Neuregulin 1 Transmembrane Domain Heterozygous Mutant Mouse

Long, L. E., Anderson, P., Frank, E., Shaw, A. D., Liu, S., Huang, X., Pinault, D., Karl, T., O'Brien, T. J., Weickert, C. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124114 · Cited by 22 · see citing works

Long-term differential effects of chronic young-adult corticosterone exposure on anxiety and depression-like behaviour in BDNF heterozygous rats depend on the experimental paradigm used

Gururajan, A., Hill, R., & van den Buuse, M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.05.041 · Cited by 21 · see citing works

Effects of nerve growth factor (NGF), fluoxetine, and amitriptyline on gene expression profiles in rat brain

McGeary, J. E., Gurel, V., Knopik, V. S., Spaulding, J., & McMichael, J. C. (2011) · Neuropeptides · doi:10.1016/j.npep.2011.06.002 · Cited by 19 · see citing works

Bipolar Disorder, Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism and Brain Morphology

Teh, C. A., Lee, T.-S. W., Kuchibhatla, M. N., Ashley‐Koch, A. E., MacFall, J. R., Krishnan, R. R., & Beyer, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038469 · Cited by 19 · see citing works

FGFR2 is associated with bipolar disorder: A large-scale case–control study of three psychiatric disorders in the Chinese Han population

Wang, T., Zeng, Z., Hu, Z., Zheng, L., Li, T., Li, Y., Liu, J., Li, J., Feng, G., He, L., et al. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.650203 · Cited by 19 · see citing works

Assessment of a Multi-Assay Biological Diagnostic Test for Mood Disorders in a Japanese Population

Yamamori, H., Ishima, T., Yasuda, Y., Fujimoto, M., Kudo, N., Ohi, K., Hashimoto, K., Takeda, M., & Hashimoto, R. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.019 · Cited by 19 · see citing works

IGF1, growth pathway polymorphisms and schizophrenia: A pooling study

Gunnell, D., Lewis, S. J., Wilkinson, J., Georgieva, L., Davey, G. S., Day, I. N. M., Holly, J. M. P., O’Donovan, M. C., Owen, M. J., Kirov, G., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30396 · Cited by 18 · see citing works

Neurobehavioral deficits of epidermal growth factor-overexpressing transgenic mice: Impact on dopamine metabolism

Eda, T., Mizuno, M., Araki, K., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.055 · Cited by 17 · see citing works

Fibroblast growth factor deficiencies impact anxiety-like behavior and the serotonergic system

Brooks, L. R., Enix, C. L., Rich, S. C., Magno, J. A., Lowry, C. A., & Tsai, P. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.053 · Cited by 16 · see citing works

Inactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors

Yamanaka, Y., Kitano, A., Takao, K., Prasansuklab, A., Mushiroda, T., Yamazaki, K., Kumada, T., Shibata, M., Takaoka, Y., Awaya, T., et al. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.09.003 · Cited by 15 · see citing works

Effects of Serotonin on Erythropoietin Expression in Mouse Hippocampus

Choi, M., & Son, H. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.45 · Cited by 15 · see citing works

The cytokines are coming.

Windebank, K. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.11.1283 · Cited by 5 · see citing works

[Research on association of BDNF gene Val66Met polymorphism with efficacy of antidepressants and plasma BDNF level].

Shen, X., Qian, M., Yuan, Y., et al. (2014) · PubMed · doi:10.3760/cma.j.issn.1003-9406.2014.02.015 · Cited by 5 · see citing works

Association between the Epidermal Growth Factor Gene and Intelligence in Major Depression Patients

Tian, W., Zhang, K.-R., Zhang, J., et al. (2010) · 中国医学科学杂志：英文版 · doi:10.1016/s1001-9294(10)60031-4 · Cited by 3 · see citing works

Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation

Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750 · see citing works

BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review

Nieto, R. R., Carrasco, A., Corral, S., Castillo, R., Gaspar, P. A., Bustamante, M. L., & Silva, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.662407 · Cited by 83 · see citing works

Revealing the Potency of Growth Factors in Bovine Colostrum

Yalçıntaş, Y. M., Duman, H., López, J. M. M., Portocarrero, A. C. M., Lombardo, M., Khallouki, F., Koch, W., Bordiga, M., El-Seedi, H., Raposo, A., et al. (2024) · Nutrients · doi:10.3390/nu16142359 · Cited by 31 · see citing works

Intraventricular infusion of nerve growth factor (NGF)

ETO, K. (1992) · Juntendō Igaku/Juntendo igaku · doi:10.14789/pjmj.38.56

APPLICATION OF DRUG DESIGN METHODS FOR INDUCING NERVE GROWTH FACTOR BIOSYNTHESIS

Κουρουνάκη, Α. (1995) · doi:10.12681/eadd/5220

[Nerve growth factor (NGF)--the current state of knowledge].

Am, D., & Bock, E. (1989) · PubMed

7S nerve growth factor has different biological activity from 2.5S nerve growth factor in vitro

Shao, N., Wang, H., Tingchong, Z., et al. (1993) · Brain Research · doi:10.1016/0006-8993(93)90893-r · Cited by 6 · see citing works

Effect of nerve growth factor on lesioneo PC12 cells

PECHA, P., IKOVA, D., MURGAOVA, M., & MALATOVA, E. (1991) · Cell Biology International Reports · doi:10.1016/0309-1651(91)90121-x · Cited by 8 · see citing works